1. Home
  2. LEG vs NVAX Comparison

LEG vs NVAX Comparison

Compare LEG & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leggett & Platt Incorporated

LEG

Leggett & Platt Incorporated

HOLD

Current Price

$11.19

Market Cap

1.5B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$7.51

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEG
NVAX
Founded
1883
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
LEG
NVAX
Price
$11.19
$7.51
Analyst Decision
Hold
Hold
Analyst Count
4
9
Target Price
$10.50
$11.33
AVG Volume (30 Days)
2.5M
3.6M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
1.85%
N/A
EPS Growth
145.31
309.76
EPS
0.14
N/A
Revenue
$5,203,900,000.00
$1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.73
N/A
P/E Ratio
$75.71
N/A
Revenue Growth
1.37
64.69
52 Week Low
$7.86
$6.20
52 Week High
$13.00
$11.85

Technical Indicators

Market Signals
Indicator
LEG
NVAX
Relative Strength Index (RSI) 53.98 30.13
Support Level $10.72 $6.38
Resistance Level $11.42 $10.10
Average True Range (ATR) 0.42 0.37
MACD -0.06 -0.14
Stochastic Oscillator 57.69 2.03

Price Performance

Historical Comparison
LEG
NVAX

About LEG Leggett & Platt Incorporated

Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the maximum of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: